Artemis Resources ( ($AU:ARV) ) has issued an announcement. Artemis Resources has announced that director Julian Hanna ceased to be a director of ...

Part of Armada’s Zero Series, the ARV 116 JJ UL is the lighter, hybrid resort/backcountry version of the ARV 116 JJ. Armada says it “floats like a butterfly and cuts like a butter knife,” a ...

Throughout the ski industry, few bands have marched to the beat of their own drum like Armada has, combining decades-long core street cred with creatively unorthodox ideas and extremely well-made skis ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

ARV is the property's value after renovations, calculated using recent sales of similar nearby properties. To determine ARV, average the sales price of comparable properties, adjusting for size and ...

Arvinas (ARVN) announced preclinical data for ARV-806, a PROTAC KRAS G12D degrader, at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, ...

NEW HAVEN, Conn., Oct. 05, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ...

(RTTNews) - Arvinas Inc. (ARVN), a clinical-stage biotechnology company, Friday announced promising first-in-human data for ARV-102, an investigational oral PROTAC designed to target and degrade LRRK2 ...

ARV-393 is an investigational PROteolysis TArgeting Chimera (PROTAC) designed to degrade B-cell lymphoma 6 protein (BCL6), a transcriptional repressor and major driver of B-cell lymphomas. The BCL6 ...

Arvinas, Inc. announced that it will present new preclinical data on its investigational oral PROTAC BCL6 degrader, ARV-393, at the upcoming European Hematology Association (EHA) meeting in Milan from ...